Comparison of Select analytes in Exhaled aerosol from E-Cigarettes with Exhaled Smoke from a Conventional Cigarette and Exhaled Breaths
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Long (2014)
Effects of Electronic Cigarette Liquid Nicotine Concentration on Plasma Nicotine and Puff Topography in Tobacco Cigarette Smokers: a Preliminary Report
Individual Clinical
User Topography
Lopez (2016)
Comparison of Urinary Biomarkers of Exposure in humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Lorkiewicz (2019)
addicted to smoking or addicted to nicotine? a focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non-smokers and dual users of cigarettes and e-cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loud (2022)
Electronic nicotine delivery systems (ENDS) dependence among Texas Young adults, 2014-2019: Increasing trajectory after the 2017 surge in vape pod popularity.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loukas (2022)
Electronic nicotine delivery systems use predicts transitions in cigarette smoking among young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Loukas (2022)
Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Lunell (2020)
Intravenous glycerol and mannitol therapy in children with intracranial hypertension
Individual Clinical
MacDonald and Uden (1982)
Inhibition of human Liver Microsomal (S)-Nicotine Oxidation by (−)-Menthol and analogues
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
MacDougall (2003)
e-Cigarette and Conventional Tobacco Cigarette Use, Dual Use, and C-Reactive Protein.
Individual Clinical
Safety
Adverse Effects
Mainous (2020)